DayDose ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  7.1% 7.1% 7.1% 7.1% 1.5%  
Bankruptcy risk  8.2% 9.1% 6.6% 5.6% 6.0%  
Credit score (0-100)  31 27 35 40 38  
Credit rating  BB BB BBB BBB BBB  
Credit limit (kDKK)  -0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  -5,476 -1,828 -426 -187 -324  
EBITDA  -8,232 -2,132 -426 -187 -324  
EBIT  -14,266 -3,740 -483 -187 -324  
Pre-tax profit (PTP)  -14,965.0 -3,842.0 -431.0 -214.0 -335.0  
Net earnings  -11,677.0 -2,996.0 -321.0 -167.0 -262.0  
Pre-tax profit without non-rec. items  -14,965 -3,842 -431 -214 -335  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  232 57.0 0.0 0.0 0.0  
Shareholders equity total  4,981 1,985 1,664 1,497 1,235  
Interest-bearing liabilities  326 2,498 360 430 453  
Balance sheet total (assets)  6,935 4,546 2,075 1,950 1,690  

Net Debt  -840 2,225 355 -247 79.0  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -5,476 -1,828 -426 -187 -324  
Gross profit growth  -373.3% 66.6% 76.7% 56.1% -73.3%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  6,935 4,546 2,075 1,950 1,690  
Balance sheet change%  -25.1% -34.4% -54.4% -6.0% -13.3%  
Added value  -8,232.0 -2,132.0 -426.0 -130.0 -324.0  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -11,438 -2,940 -114 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -2.0 -3.0 -4.0 -5.0 -5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  260.5% 204.6% 113.4% 100.0% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -164.1% -65.0% -11.5% -9.2% -17.0%  
ROI %  -188.4% -76.2% -11.7% -9.4% -17.2%  
ROE %  -163.9% -86.0% -17.6% -10.6% -19.2%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  71.8% 43.7% 80.2% 76.8% 73.1%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  10.2% -104.4% -83.3% 132.1% -24.4%  
Gearing %  6.5% 125.8% 21.6% 28.7% 36.7%  
Net interest  0 0 0 0 0  
Financing costs %  14.0% 7.9% 3.5% 7.3% 5.7%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  1.9 1.3 3.0 3.1 3.1  
Current Ratio  2.3 1.3 3.0 3.1 3.1  
Cash and cash equivalent  1,166.0 273.0 5.0 677.0 374.0  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  2,507.0 837.0 838.0 934.0 933.0  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0